12-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of bi-annual treatment with ivermectin and albendazole.

about

Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.

P2860

Q42284546-2D7F0FE2-B487-4D13-9948-DC39269CB610

P2860

12-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of bi-annual treatment with ivermectin and albendazole.

Item

http://www.wikidata.org/entity/Q40048094

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

12-month longitudinal parasito ...... th ivermectin and albendazole.

@en

type

Item

label

12-month longitudinal parasito ...... th ivermectin and albendazole.

@en

prefLabel

12-month longitudinal parasito ...... th ivermectin and albendazole.

@en

P1476

12-month longitudinal parasito ...... th ivermectin and albendazole.

@en

P2093

Bethel Kwansa-Bentum

http://www.w3.org/2001/XMLSchema#string

Daniel A Boakye

http://www.w3.org/2001/XMLSchema#string

Fred Aboagye-Antwi

http://www.w3.org/2001/XMLSchema#string

John N Kanamitie

http://www.w3.org/2001/XMLSchema#string

Joseph Otchere

http://www.w3.org/2001/XMLSchema#string

Michael D Wilson

http://www.w3.org/2001/XMLSchema#string

Nana-Kwadwo Biritwum

http://www.w3.org/2001/XMLSchema#string

P2860

An analysis of genetic diversity and inbreeding in Wuchereria bancrofti: implications for the spread and detection of drug resistance

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis

Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease

Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys

Can Lymphatic Filariasis Be Eliminated by 2020?

Neglected tropical diseases: progress towards addressing the chronic pandemic.

Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration.

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.

P304

1451-1456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TMI.12974

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dziedzom K de Souza

Collins K. Ahorlu

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28891597

http://www.w3.org/2001/XMLSchema#string

P921

ivermectin

filariasis

12-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of bi-annual treatment with ivermectin and albendazole.

about

P2860

P2860

12-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of bi-annual treatment with ivermectin and albendazole.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921